ArticleCureus2026
Transvenous Embolization of Olfactory Groove Dural Arteriovenous Fistula: A Case Series of Three Patients.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olfactory groove or anterior cranial fossa (ACF) dural arteriovenous fistulas (DAVFs) are rare but highly aggressive lesions because of their direct cortical venous drainage and high risk of intracranial hemorrhage. Transarterial embolization (TAE) is commonly considered the first-line treatment; however, anatomical complexity or arterial limitations may make TAE technically difficult or unsafe. We present a case series of three patients with olfactory groove DAVFs successfully treated using transvenous embolization (TVE). In all cases, the fistulous point was accessed through the superior sagittal sinus and cortical bridging veins, allowing targeted coil embolization of the draining vein. Complete angiographic obliteration was achieved in all patients. One patient developed neurological deficits related to a thromboembolic event during arterial catheterization, while the remaining two patients had uneventful recoveries. Our experience suggests that TVE can be a feasible and effective treatment option for selected olfactory groove DAVFs, particularly in cases where arterial access is challenging or when previous transarterial treatment has failed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.